Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Puma Biotechnology, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 83 | 89 | +6 |
| Shares | 27.7M | 27.5M | −156.0K (−0.6%) |
| Value | $65.5M | $116.3M | +$50.8M (+77.5%) |
New holders (21)
Institutions that held Puma Biotechnology, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hillsdale Investment Management Inc. | 666,206 | $2.82M | 0.24% |
| Marshall Wace, LLP | 321,257 | $1.36M | 0.00% |
| EAM Investors, LLC | 272,787 | $1.15M | 0.24% |
| Virtu Financial LLC | 49,760 | $210.0K | 0.03% |
| Jump Financial, LLC | 46,834 | $198.1K | 0.01% |
| Jane Street Group, LLC | 40,818 | $172.7K | 0.00% |
| 683 Capital Management, LLC | 36,500 | $154.4K | 0.01% |
| Bank of Montreal | 32,265 | $148.1K | 0.00% |
| HRT Financial LP | 30,416 | $128.0K | 0.00% |
| Acrisure Capital Management, LLC | 25,409 | $107.5K | 0.12% |
| Occudo Quantitative Strategies LP | 22,279 | $94.2K | 0.01% |
| Boothbay Fund Management, LLC | 20,218 | $85.5K | 0.00% |
| Charles Schwab Investment Management Inc | 19,453 | $82.3K | 0.00% |
| PDT Partners, LLC | 19,146 | $81.0K | 0.01% |
| Squarepoint Ops LLC | 17,893 | $75.7K | 0.00% |
| Bayesian Capital Management, LP | 11,901 | $50.3K | 0.01% |
| Commonwealth Equity Services, LLC | 10,859 | $45.0K | 0.00% |
| Prudential Financial Inc | 10,600 | $44.8K | 0.00% |
| Freedom Wealth Alliance, LLC | 1,721 | $7.28K | 0.01% |
| Dark Forest Capital Management LP | 1,675 | $7.08K | 0.00% |
| Royal Bank of Canada | 100 | $0 | 0.00% |
Sold out (15)
Institutions that held Puma Biotechnology, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Russell Investments Group, Ltd. | 99,139 | $234.0K |
| Ally Bridge Group (NY) LLC | 64,295 | $152.0K |
| Price T Rowe Associates Inc | 45,400 | $108.0K |
| Atria Wealth Solutions, Inc. | 25,200 | $59.7K |
| Diversified Trust Co | 20,175 | $48.0K |
| HSBC Holdings PLC | 18,913 | $45.0K |
| Simplex Trading, LLC | 15,946 | $37.0K |
| Cambridge Investment Research Advisors, Inc. | 14,945 | $35.0K |
| Balyasny Asset Management LLC | 13,851 | $33.0K |
| LMR Partners LLP | 11,514 | $27.0K |
| Leonteq Securities AG | 6,000 | $14.2K |
| Quantbot Technologies LP | 4,489 | $10.0K |
| China Universal Asset Management Co., Ltd. | 426 | $1.00K |
| Daiwa Securities Group Inc. | 87 | $0 |
| Quent Capital, LLC | 143 | $0 |